Mechanism of action of immunomodulatory agents in multiple myeloma

Author： Reske Thomas   Fulciniti Mariateresa   Munshi Nikhil  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.27, Iss.1, 2010-06, pp. : 7-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonates - Mechanisms of Action in Multiple Myeloma

By Shipman Claire M.   Rogers Michael J.   Vanderkerken Karin   Van Camp Ben   Russell R. Graham G.   Croucher Peter I.  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 829-835

Informa Healthcare

Access to resources Recommend Favorite

Arsenic trioxide: A new immunomodulatory agent in the management of multiple myeloma

By Hussein Mohamad  

Medical Oncology, Vol. 18, Iss. 4, 2001-12 ,pp. : 239-242

Humana Press, Inc

Access to resources Recommend Favorite

Monitoring the Action of Clodronate with Type I Collagen Metabolites in Multiple Myeloma

By Finnish Leukaemia Group   Elomaa I.   Risteli L.   Laakso M.   Lahtinen R.   Virkkunen P.   Risteli J.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1166-1170

Elsevier

Access to resources Recommend Favorite

The mechanism study of miR‐125b in occurrence and progression of multiple myeloma

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 134-145

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 3, 2005-05 ,pp. : 201-213

Bentham Science Publishers

Access to resources Recommend Favorite